학술논문
OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study
Document Type
Article
Author
Leighl, N.; Cho, B.C.; Hiret, S.; Han, J.-Y.; Lee, K.H.; Llacer Perez, C.; Krebs, M.G.; De Braud, F.; Haura, E.; Sanborn, R.E.; Yang, J.C.-H.; Shu, C.A.; Goto, K.; Nishio, M.; Zhao, J.; Wang, Z.; Tomasini, P.; Felip, E.; Goldman, J.W.; Ou, S.-H.I.; Boyer, M.; Gao, G.; Qu, S.; Curtin, J.C.; Lyu, X.; Roshak, A.; Schnepp, R.W.; Kim, P.; Mertz, J.; Thayu, M.; Shreeve, S.M.; Knoblauch, R.E.; Spira, A.I.
Source
Journal of Thoracic Oncology; November 2023, Vol. 18 Issue: 11, Number 11 Supplement 1 pS93-S94, 2p
Subject
Language
ISSN
15560864; 15561380